foxo4 dri human clinical trial Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging FOXO4-DRI Vial 10mg — Stemcode
Description
Catumaxomab is a bispecific antibody against EpCAM and CD3, which brings T cells closer to EpCAM+ cells
FOXO4-DRI reduces chemotherapy-induced senescence and chemotoxicity and cellular senescence in p16-positive aging XpdTTD/TTD mice 11
And these arent the only sources of confusion
FOXO4-DRI is a D-retro-inverso peptide built from a FOXO4 fragment that binds p53, joined to a cell-penetrating sequence, with a molecular weight near 4.8 kDa
These peptides and stimulating hormones cost dramatically less and produce great results
E.FearingB
